fulvestrant has been researched along with Melanoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artham, S; Bae, Y; Baldi, R; Brueckner, O; Byemerwa, J; Chakraborty, B; Chang, CY; Gong, W; Haines, CN; Hanks, BA; Lim, F; Liu, W; McDonnell, DP; Mukherjee, D; Perou, CM; Shepherd, J; Tavares, K; Wardell, SE | 1 |
| Adams, DJ; Boland, GM; Cichowski, K; Crawford, L; Flaherty, KT; Frederick, DT; Herlyn, M; Krepler, C; Liberti, MV; Liu, X; Locasale, JW; Maertens, O; Magpusao, AN; Manchester, HE; McCall, SJ; Mukherjee, S; Singleton, KR; Sproesser, K; Stein, EM; Tingley, JP; Tsui, E; Wood, KC | 1 |
| DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
| Dewhurst, LO; Gee, JW; MacNeil, S; Rennie, IG | 1 |
4 other study(ies) available for fulvestrant and Melanoma
| Article | Year |
|---|---|
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Humans; Immune System; Macrophages; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Neoplasm Metastasis; Receptors, Estrogen; RNA, Small Cytoplasmic; Signal Transduction; Skin Neoplasms; Tumor Microenvironment | 2021 |
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.
Topics: Antineoplastic Agents, Hormonal; Benzimidazoles; Cell Line, Tumor; Estradiol; Evolution, Molecular; Female; Fulvestrant; Humans; Imidazoles; Indoles; Male; Melanoma; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; Pyridones; Pyrimidinones; Quinolines; Signal Transduction; Sulfonamides | 2017 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin.
Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Estradiol; Fibronectins; Fulvestrant; Humans; Melanoma; Naphthalenes; Neoplasm Invasiveness; Receptors, Progesterone; Skin Neoplasms; Sulfonamides; Tamoxifen; Uveal Neoplasms | 1997 |